We moved into a new and larger office space!
Given the growth of our team over the past year, we were excited to open our new office in December.
The new space offers more individual work stations, collaborative areas for project teams to work together, and we didn’t forget our always competitive foosball table.
Latest Insights
Jump to a slide with the slide dots.
Ashwini Chidirala
Overcoming the Challenges in Bringing Cell & Gene Therapies to Market
Overcome CGT capacity challenges with strategies for forecasting, staffing, and treatment center partnerships.
Read more
Ashwini Chidirala
Overcoming the Challenges in Bringing Cell & Gene Therapies to Market – Part 2
How CGT manufacturers can reduce treatment center burden through better workflows, training, logistics, and system integration.
Read more
Ashwini Chidirala
Overcoming the Challenges in Bringing Cell & Gene Therapies to Market – Part 3
How CGT manufacturers can reduce financial risk and reimbursement burden for treatment centers adopting commercial therapies.
Read more
Natalie Gier
Free Drug and Access Equation: What Regeneron’s Otarmeni Decision Reveals About Specialty Product Access
Free drug removes price barriers, but Otarmeni shows why specialty therapy access still depends on PSPs, payers, and logistics.
Read more
Ashwini Chidirala
Overcoming the Challenges in Bringing Cell & Gene Therapies to Market – Part 4
As cell and gene therapies (CGTs) continue to enter the market, treatment centers have become the primary gatekeepers...
Read more